Mylan's Generic Copaxone Arrives, Teva Sales To Take A Hit
October 04, 2017 at 11:40 AM EDT
The FDA dealt yet another blow to struggling Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) investors by approving rival Mylan ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.